Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.

导出 LinkOut

翻译打印收藏纠错

第一作者： William J,Muller

第一单位： Northwestern University, Chicago, IL.

作者： William J,Muller ^[1] ; Shabir A,Madhi ^[2] ; Beatriz,Seoane Nuñez ^[3] ; Manuel,Baca Cots ^[4] ; Miroslava,Bosheva ^[5] ; Ron,Dagan ^[6] ; Laura L,Hammitt ^[7] ; Conrado J,Llapur ^[8] ; Jose M,Novoa ^[9] ; Xavier,Saez Llorens ^[10] ; Amy,Grenham ^[11] ; Elizabeth J,Kelly ^[11] ; Vaishali S,Mankad ^[12] ; Manish,Shroff ^[13] ; Therese,Takas ^[14] ; Amanda,Leach ^[14] ; Tonya,Villafana ^[14] ; MELODY Study Group

作者单位： Northwestern University, Chicago, IL. ^[1] University of the Witwatersrand, Johannesburg, South Africa. ^[2] AstraZeneca, Barcelona, Spain. ^[3] Quirónsalud Málaga Hospital, Malaga, Spain. ^[4] St. George Medical University, Plovdiv, Bulgaria. ^[5] Ben-Gurion University of the Negev, Beer-Sheva, Israel. ^[6] Johns Hopkins University, Baltimore, MD. ^[7] Hospital del Niño Jesús, San Miguel de Tucumán, Argentina. ^[8] Hospital Padre Hurtado, Santiago, Chile. ^[9] Cevaxin Research Center, Panama City, Panama. ^[10] AstraZeneca, Gaithersburg, MD. ^[11] AstraZeneca, Durham, NC. ^[12] AstraZeneca, Waltham, MA. ^[13] AstraZeneca, Gaithersburg, MD tonya.villafana@astrazeneca.com. ^[14]